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The present investigation aims to evaluate an isotropic and thermodynamically stable nanoemulsion 
formulation for transdermal delivery of glycyrrhizin (GZ), with minimum surfactant and cosurfactant 
(Smix) concentrations that could improve its solubility, permeation enhancement, and stability. Pseudo-
ternary phase diagrams were developed and various nanoemulsion formulations were prepared using 
soyabean oil as oil, Span 80, Brij 35 as a surfactant and isopropyl alcohol as a cosurfactant. Nanoemulsion 
formulations that passed the thermodynamic stability tests were characterized for pH, viscosity and 
droplet size using a transmission electron microscopy. The transdermal ability of glycyrrhizin through 
human cadaver skin was determined using Franz diffusion cells. The in vitro skin permeation profile of 
the optimized nanoemulsion formulation (NE2) was compared to that of conventional gel. A significant 
increase in permeability parameters such as steady-state flux (Jss) and permeability coefficient (Kp) 
was observed in the optimized nanoemulsion formulation (NE2), which consisted of 1% wt/wt of 
mono ammonium glycyrrhizinate (MAG), 32.4% Span 80, 3.7% Brij 35, 10% isopropyl alcohol, 
46.5% soyabean oil and 6.4% distilled water. No obvious skin irritation was observed for the studied 
nanoemulsion formulation (NE2) or the gel. The results indicated that nanoemulsions are promising 
vehicles for transdermal delivery of glycyrrhizin through human cadaver skin, without the use of additional 
permeation enhancers, because excipients of nanoemulsions act as permeation enhancers themselves.
Uniterms: Nanoemulsions/use/in vitro skin permeation. Glycyrrhizin/transdermal delivery. Isotropic 
nanoemulsion formulation/evaluation. Anti-inflammatories/transdermal delivery. Surfactants. Permeation/
enhancers/in vitro study. 
O objetivo da investigação é avaliar uma nanoemulsão isotrópica termodinamicamente estável para a 
administração transdérmica da glicirrizina (GZ), com concentrações mínimas de tensoativo e co-tensoativo 
(Smix), que poderiam melhorar a sua solubilidade, a permeação e a estabilidade. Os diagramas pseudo-
ternários de fase foram desenvolvidos e diversas nanoemulsões foram preparadas com óleo de soja como 
óleo, Span 80, Brij 35 como tensoativos e álcool isopropílico como co-tensoativo. As nanoemulsões que 
passaram por testes de estabilidade termodinâmica foram caracterizadas por pH, viscosidade, tamanho 
de gota e microscopia eletrônica de transmissão. A capacidade transdérmica da glicirrizina em passar 
através da pele de cadáver humano foi determinada por células de difusão de Franz. O perfil in vitro de 
permeação cutânea da formulação otimizada (NE2) foi comparada com a de gel convencional. Observou-
se aumento significativo nos parâmetros de permeabilidade, como fluxo de equilíbrio (JSS) e coeficiente 
de permeabilidade (Kp) na formulação otimizado (NE2), que consistiu de 1% wt/wt de monoglicirrizinato 
de amônio (MAG), 32,4% de Span 80, 3,7% de Brij 35, 10% de álcool isopropílico, 46,5% de óleo de 
soja e 6,4% de água destilada. Não se observou irritação óbvia da pele para as nanoemulsões estudadas 
(NE2) ou de gel. Os resultados indicaram que nanoemulsões são promissores veículos para a administração 
transdérmica de glicirrizina através da pele de cadáveres humanos, sem o uso adicional de promotor de 
permeação, porque excipientes de nanoemulsões atuam como promotores de permeação.
Unitermos: Nanoemulsão/uso/permeação cutânea in vitro. Glicirrizina/administração transdérmica. 
Nanoemulsão isotrópica/avaliação. Anti-inflamatórios/administração transdérmica. Tensoativos. 
Permeação/promotores/in vitro study.
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INTRODUCTION
Glycyrrhizin (GZ) (Figure 1), a major component 
of liquorice (Glycyrrhiza glabra L.), is used as a remedy 
for chronic hepatitis, allergies, and other ailments (Koga 
et al., 2004). It has been reported that liquorice is effec-
tive in gastric ulcer treatment (Bennet et al., 1985), and 
glycyrrhetinic acid  the aglycone of glycyrrhizin  
has anti-inflammatory and antiulcer effects (Yano et al., 
1989). Liquorice constituents also exhibit anti-arthritic, 
anti-arrhythmic, antibacterial, antiviral, expectorant and 
steroid-like anti-inflammatory activity, similar to the ac-
tion of hydrocortisone. This is due, in part, to inhibition 
of phospholipase A2 activity, an enzyme critical to nu-
merous inflammatory processes (Okimasu et al., 1983). 
In vitro research has also demonstrated that glycyrrhizic 
acid inhibits cyclooxygenase activity and prostaglandin 
formation (specifically, prostaglandin E2), as well as 
indirectly inhibiting platelet aggregation, all factors in-
volved in inflammatory process (Okimasu, 1983; Ohuchi, 
Tsurufuji, 1982). It is now known that glycyrrhizic acid 
and its aglycone glycyrrhetinic acid, present in the root 
extract, are responsible for biological activities (Gibson, 
1978; Norman et al., 1995). It is currently used extensively 
in the tobacco, food, confectionery, and pharmaceutical 
industries, throughout the world (Baker, 1995). One of 
the promising technologies for enhancing transdermal 
permeation of drugs is nanoemulsion. Nanoemulsions 
are thermodynamically stable, transparent (or translucent) 
dispersions of oil and water stabilized by an interfacial film 
of surfactant molecules with droplet size below 100 nm. 
Nanoemulsion provides ultra low interfacial tensions and 
large o/w interfacial areas. Nanoemulsions have higher 
solubilization capacity than simple micellar solutions 
and their thermodynamic stability offers advantages over 
unstable dispersions, such as emulsions and suspensions, 
because they can be manufactured with little energy input 
(heat or mixing) and have a long shelf life. The nanosized 
droplets leading to enormous interfacial areas associated 
with nanoemulsions appear to influence the transport 
properties of the drug, an important factor in sustained and 
targeted drug delivery (Eccleston, 1994; Lawrence, Rees, 
2000). The appeal of formulating o/w nanoemulsion sys-
tems lies in their ability to incorporate hydrophobic drugs 
into the oil phase, thereby enhancing solubility (Lawrence, 
Rees, 2000). Nanoemulsions have been reported to make 
the plasma concentration profiles and bioavailability of 
drugs more reproducible (Kommuru et al., 2001; Law-
rence, Rees, 2000; Constantinides, 1995; Kawakami et 
al., 2002). Transdermal delivery of drugs through the skin 
to the systemic circulation excels by avoiding the hepatic 
first-pass metabolism, as well as by its potential of long 
term controlled release, avoiding the typical peak trough 
plasma-profiles associated with frequent dosage regi-
ments. Transdermal delivery also presents with ease of ad-
ministration and the possibility of immediate withdrawal 
of treatment, providing a convenient route of adminis-
tration for a variety of clinical indications (Kreilgaard, 
2002; Benson, 2005). Nanoemulsions can enhance the 
transdermal permeation of drugs via their finely dispersed 
oil droplet phase. Additionally, the diffusional barrier of 
the skin may be modified depending on the composition 
of the nanoemulsion. Also, an increased thermodynamic 
activity of the drug may favour its partitioning into the 
skin (Baroli et al., 2000; Moulik et al., 2001). This article 
describes the potential of nanoemulsions systems in trans-
dermal delivery of glycyrrhizin through human cadaver 
skin, without the use of additional permeation enhancers, 
because excipients of nanoemulsions themselves act as 
permeation enhancers.
MATERIAL AND METHODS
Materials
The standard compound mono ammonium glycyr-
rhizinate (MAG) was purchased from Fisher Scientific, 
India. Brij 35, Span 80, soyabean oil, isopropyl alcohol, 
ethanol and Carbopol 940 were purchased from Himedia 
Chemicals, Delhi, India. Purified water, solvent and other 
chemicals were of analytical grade.
Construction of pseudo-ternary phase diagrams
In response to finding the concentration range of 
ingredients for the existing range of nanoemulsions, 
pseudo-ternary phase diagrams were constructed, using 
FIGURE 1- Structure of glycyrrhizin.
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TABLE I - Compositions of the selected nanoemulsion formulations
Components NE1 NE2 NE3 NE4 NE5
MAG % 1.0 1.0 1.0 1.0 1.0
Water % 7.40 6.4 6.0 6.0 5.0
Span 80% 29 32.4 36 40.0 43.0
Brij 35% 3.3 3.7 4.0 4.0 5.0
Isopropyl alcohol % 9.0 10.0 11.0 12.0 13.0
Soyabean oil % 50.3 46.5 42.0 37.0 33.0
TABLE II - Formula for preparation of glycyrrhizin gel*
Glycyrrhizin gel Ingredients (for 100 g of gel)
MAG (% wt/wt) 1
Carbopol 940 (% wt/wt) 1
IPA(% wt/wt) 10
PEG-400 (% wt/wt) 10
PG (% wt/wt) 10
TEA (g) 0.5
Distilled water (qs) 100
*IPA indicates isopropyl alcohol; PEG, polyethylene glycol; PG, 
propylene glycol; TEA, triethanolamine; qs, quantity sufficient.
the water titration method at room temperature (25 oC). 
Three phase diagrams were chosen, with 3:1, 4:1 and 5:1 
weight ratios of Span 80 and Brij 35 to isopropyl alcohol, 
respectively, and are shown in Figure 2. The ratios of oil 
to the mixture of S:Cos, for each phase diagram at a spe-
cific S:Cos weight ratio, varied: 9.5:0.5, 9:1, 8.5:1.5, 8:2, 
7.5:2.5, 7:3, 6.5:3.5, 6:4, 5.5:4.5, 5:5, 4.5: 5.5, 4:6, 3.5:6.5, 
3:7, 2.5:7.5, 2:8, 1.5:8.5, 1:9, 0.5:9.5. The mixtures of oil, 
S:Cos (Smix) at certain weight ratios were diluted by add-
ing water dropwise, under specific magnetic stirring. After 
being equilibrated, the mixtures were assessed physically 
and determined as being nanoemulsions. 
Preparation of nanoemulsions
Nanoemulsion regions were identified based on 
phase diagrams, and the nanoemulsion formulations 
were selected at different ingredients ratios, as described 
in Table I. Nanoemulsions loaded with MAG, prepared 
with the mixture of soyabean oil and isopropyl alcohol; 
a stock solution containing MAG. The clear oily phase 
containing MAG was obtained by diluting the weighed 
amount of stock solution with soyabean oil and isopropyl 
alcohol. Span 80 and Brij 35 were dissolved in distilled 
water and added to the clear oily phase, drop by drop. 
Water-in-oil (w/o) nanoemulsions containing MAG were 
obtained under a magnetic stirring at room temperature. 
All formulations contained 1% w/w mono ammonium 
glycyrrhizate.
Characterization of nanoemulsions
Morphology and structure of the nanoemulsions 
were studied using a transmission electron microscope 
(TEM) (Hitachi H-7500, Japan). Samples were stained on 
a carbon-coated copper grid with a 1% aqueous solution 
of phospho tungustic acid (PTA) and observed under the 
microscope with an accelerated voltage of 100 kV. The 
pH values of nanoemulsions were determined using a pH 
meter (HACH digital pH meter, USA). The viscosity of 
various nanoemulsions was measured using a Brookfield 
digital viscometer (Model DV-II, Brookfield, USA). Mean 
droplet size and polydispersity index of the nanoemulsion 
were characterized by photon correlation spectroscopy 
(Malvern Zetasizer Nano ZS-90, Malvern instrument Ltd, 
UK). Samples were suitably diluted with distilled water 
to avoid multi-scattering phenomena. Changes in droplet 
size of the diluted nanoemuslions were not found to be 
significant. The conductivity of different nanoemulsions 
was determined using a conductometer (HACH, USA). 
All parametrs were carried out at 25 oC.
Preparation of conventional glycyrrhizin gel
Conventional glycyrrhizin gel (CG) was prepared 
by dispersing the Carbopol 940 (1 g) in a sufficient 
quantity of distilled water. After complete dispersion, 
the Carbopol 940 solution was kept in the dark for 24 
hours for complete swelling. Then mono ammonium 
glycyrrhizate (1 g) was dissolved in a specified quantity 
of polyethylene glycol 400. This drug solution was added 
slowly to the aqueous dispersion of Carbopol 940, with 
agitation. Then other ingredients like isopropyl alcohol, 
propylene glycol and triethanolamine were added to 
obtain a homogeneous dispersion of gel (Shakeel et al., 
2007) (Table II).
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Stability of nanoemulsions
The chemical and physical stability of nanoemulsions 
was studied by observation of clarity and phase separation, 
determination of droplet size and analysis of glycyrrhizin 
251 nm for 6 months, using a UV-double beam spectropho-
tometer (Shimadzu, 1800). Concentrations of glycyrrhizin 
in the nanoemulsions were estimated monthly. The centri-
fuge tests were also performed to assess the phase behavior 
of nanoemulsions. Nanoemulsions were centrifuged for 
30 min at 35,000 rpm in the centrifuge apparatus (Shafiq 
et al., 2007). Nanoemulsions were kept at 4±1, 25±1 and 
45±1 oC for 6 months. Clarity, phase separation and con-
centration of glycyrrhizin were then evaluated to find the 
optimal storage temperature, on a monthly basis.
Calibration curve
Glycyrrhizin10 mg was accurately weighed and 
dissolved in a sufficient volume of phosphate buffer in a 
100 mL volumetric flask. The final volume was made up to 
the mark with phosphate buffer to obtain a concentration 
of 100 µg/mL. This stock solution was used to prepare 
further standard solution of the drug. From the stock solu-
tion, aliquots of 0.5, 1.0, 1.5, 2.0, 2.5, 3.0, 3.5, 4.0, 4.5, and 
5.0 mL of volume, up to 10 ml were transferred to a series 
of 10 mL volumetric flask and the volume was made up to 
the mark with phosphate buffer pH 7.4. Thus, drug solution 
concentration obtained was in the range of 5-50 µg/mL. 
All the solution was filtered using Whatman filter paper 
(# 41). The absorbance of all the resultant solutions was 
measured against blank using a UV Double-beam spectro-
photometer (Shimadzu 1700, Japan) at 251 nm (Aswatha 
et al., 2010). A calibration curve was obtained: Y = MX+C; 
where M = 0.0194, C = 0.0457, and r2 = 0.9764.
In vitro permeation studies
In vitro skin permeation of MAG-loaded nanoemul-
sion formulations was studied using a locally manufac-
tured Franz diffusion cell with an effective permeation 
area and receptor cell volume of 2.5 cm2 and 10 ml, respec-
tively. The temperature was maintained at 37±0.5 °C. The 
receptor compartment contained 10 ml phosphate buffer 
(pH 7.4) and was constantly stirred by a magnetic stirrer 
(Expo India Ltd., Mumbai, India) at 600 rpm. Dermatomed 
(500 μm thickness) human cadaver skin from abdominal 
areas was obtained from the Chhattisgarh Institute of 
Medical Sciences (Bilaspur, India), and stored in a deep 
freezer at −20 °C until further use. The skin was then care-
fully checked through a magnifying glass to ensure that 
samples were free from any surface irregularity, such as 
tiny holes or crevices in the portion that was to be used 
for transdermal permeation studies (Dubey et al., 2007). 
After verification, the skin was mounted onto a receptor 
compartment with the stratum corneum side facing the 
donor compartment. The donor compartment contained 
1 g of the sample and sealed with paraffin film to provide 
occlusive conditions. Samples were withdrawn through 
the sampling port of the diffusion cell at predetermined 
time intervals over a period of 24 hours, then analised for 
drug content using a UV Spectrophotometer at 251 nm 
(Shimadzu 1700, Japan). The receptor phase was immedi-
ately replenished with an equal volume of fresh diffusion 
buffer. The formulation NE2 provided the highest release, 
compared to the other nanoemulsion formulations. The 
formulation NE2 was also converted into nanoemulsion 
gel formulations, by adding 1% wt/wt Carbopol 940. This 
was coded as NG2, with the Carbopol 940 used as viscos-
ity modifier and gelling agent. The skin permeation profile 
of the optimized nanoemulsion formulation was compared 
to that of the nanoemulsion gel (NG2) and conventional 
gel (CG), using Dunnett’s test of one-way analysis of 
variance (ANOVA). All experiments were performed in 
triplicate. Sink conditions were maintained throughout the 
experiment. The drug release results are shown graphically 
in Figure 3.
Determination of flux and permeability
The cumulative amount of glycyrrhizin permeating 
across the cadaver skin was plotted against time. Drug flux 
J (µg/h/cm2) at steady state was calculated by dividing the 
slope of the linear portion of the curve by the area of the 
exposed membrane surface (2.5 cm2). The permeability 
Kp (cm/h) was calculated by dividing the flux by the initial 
concentration of glycyrrhizin in the donor phase. The ex-
periment was carried out in triplicate, and results are shown 
graphically in Figure 4. In-vitro skin permeation and flux of 
selected gel formulation of nanoemulsion (NG2) in cadaver 
skin was analysed, and drug release results are graphically 
shown in Figure 5 and detailed in Table III.
Skin irritation studies
Irritation studies were carried out to determine the 
localised reaction of nanoemulsion and nanoemulsion-
based gel on the skin. For this purpose, a single 10 µL dose 
of optimized NE, NE (MAG) and NG was applied to the 
left ear of Swiss albino mice, with the right ear considered 
as control. The development of erythema was monitored 
daily for 3 days using the Utelly test (Utelly, 1973). The 
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animal experiments had been approved by our institutional 
ethics committee (IAEC/proposal No. 02/2008 Registra-
tion no. 994/ac/06/CPCSEA/23/Oct/2006). Extent of ery-
thema development was indicated on the following basis:
0: no erythema development 
2: barely visible few blood vessels and no erythema de-
velopment
4: main blood vessels more obvious and slight erythema 
development
Irritation potential was calculated using Equation 1: 
where A and B represent erythema value and correspond-
ing day, respectively (Gupta et al., 2005).
Statistical analysis
All skin permeation experiments were repeated three 
times and data were expressed as mean value ± SEM. 
Statistical data were analysed by one-way analysis of 
variance (ANOVA). A multiple comparison test was used 
to compare different formulations, and a P value of 0.05 
was considered to be significant.
RESULTS AND DISCUSSION
Phase studies
The phase diagram consists of safe constituents in-
cluding soyabean oil, isopropyl alcohol, Span 80 and Brij 
35, and water. The concentration ranges of ingredients for 
the formulation of nanoemulsions were calculated through 
the construction of phase diagrams. The pseudo-ternary 
phase diagrams with various weight ratios of Span 80 and 
Brij 35 to isopropyl alcohol are described in Figure 2.
The translucent nanoemulsion region is shown in the 
phase diagrams. The w/o nanoemulsions were observed. 
The gel region is shown to be transparent and translucent. 
On visual observation, the rest of the region on the phase 
diagram represents the turbid and conventional emulsions. 
The isotropic region of the nanoemulsion changed slightly, 
increasing in surfactant to cosurfactant ratio.
Preparation and characterisation of 
nanoemulsions
The nanoemulsions were selected from the 5:1 
phase diagram. Span 80 and Brij 35 were added into the 
FIGURE 2- Pseudo-ternary phase diagrams indicating water-in-
oil nanoemulsion region at different Smix (S:Cos) ratios.
oily phase for the construction of phase diagrams. A time 
of 1-2 hours was required in order to obtain transparent 
nanoemulsions under magnetic stirring, with nanoemul-
sions containing 32.4% Span 80, 3.7% Brij 35, 10% iso-
propyl alcohol and 46.5% soyabean oil. However, when 
Span 80 and Brij 35 were solubilised into the aqueous 
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phase, and the aqueous phase was then added to the oily 
phase containing isopropyl alcohol and soyabean oil, 
clear nanoemulsions were quickly obtained. The order 
of the addition for Span 80 and Brij 35 did not, however, 
change the physicochemical properties of the nanoemul-
sions. Therefore, in order to reduce the equilibrium time, 
Span 80 and Brij 35 were added to water in preparation 
of drug-loaded nanoemulsions. Additionally, the influence 
of the order of the addition of isopropyl alcohol over the 
preparation of nanoemulsions was also studied. When 
Span 80 and Brij 35 were added to the aqueous phase, and 
isopropyl alcohol was added to the oily phase or to the 
aqueous phase, no change in equilibrium time and in the 
physicochemical properties was observed. This is not in 
accordance with the results obtained by Vandamme (Chen 
et al., 2005; Vandamme, 2002), which stated that the order 
of the addition of the cosurfactant could influence the time 
required to achieve equilibrium. This may be due to the 
quick distribution of isopropyl alcohol between the oily 
and aqueous phases. It was concluded that the order of the 
addition of this surfactant should be a very important factor 
for the preparation of nanoemulsions. The physico-chemi-
cal parameters of nanoemulsions are reported in Table IV. 
The NE2 containing 46.5% oil, 32.4% Span 80, 3.7% Brij 
35, 10% isopropyl alcohol had the lowest mean droplet 
size, viscosity and conductivity. It was obvious that mean 
droplet size, viscosity and conductivity of nanoemulsions 
with less oil and surfactant had increased significantly. In 
the TEM positive image, the nanoemulsion appeared dark 
and the surroundings were bright (Figure 6). Some droplet 
sizes were measured, as the TEM is capable of point-to-
point resolution.
These sizes were in agreement with the droplet size 
distribution measured using photon correlation spec-
troscopy. The pH values were within the physiological 
range. The droplet size for all nanoemulsions was in the 
10-100 nm range. Mean droplet size of NE2 containing 
glycyrrhizin was 22 nm. The increase in mean droplet size 
for the nanoemulsion may be related to embedding of gly-
cyrrhizin and permeation enhancer into the interfacial film.
Stability of nanoemulsions
All nanoemulsion formulations were stable at 
45±1 oC in the presence or absence of glycyrrhizin. No 
changes of droplet size, phase separation and glycyr-
rhizin degradation were observed during 6 months. The 
centrifuge tests showed that all nanoemulsions presented 
with good physical stability. Nanoemulsions stored at 
4±1 oC, 25±1 oC and 45±1 oC showed no change in clarity 
and phase behavior. The concentrations of glycyrrhizin in 
nanoemulsions were almost constant and no degradation 
was observed. However, phase separation and turbidity 
were observed for nanoemulsions at 4 oC. Coagulation of 
the internal phase might have led to this instability. But 
these nanoemulsions were easily recovered when heated. 
Thus, nanoemulsions should be stored at temperatures 
above 4 oC, at least. Long-term storage of glycyrrhizin in 
an aqueous environment may result in a potential tendency 
for hydrolysis. Therefore, it is disadvantageous that the 
glycyrrhizin was formulated to an aqueous environment. 
The rate of hydrolysis of glycyrrhizin is also significantly 
influenced by the pH value. Especially when the pH value 
is less than 3 or more, hydrolysis of glycyrrhizin could 
occur. However, when the pH value ranges from 6.5 to 
8.5, hydrolysis can be inhibited. All nanoemulsions had 
TABLE IV - Physicochemical parameter of the various nanoemulsions
Formulation code Droplet size 
(nm)
Polydispersity 
index
pH Viscosity 
(cP)
Conductivity 
(µS/cm)
NE1
NE2
NE3
NE4
NE5
35
22
34
45
69
0.316
1.000
1.000
1.000
1.000
6.75
6.70
6.78
6.85
7.21
97.78
98.08
98.02
98.00
98.05
16.9
17.9
18.8
20.2
18.5
NE1-5 indicates nanoemulsion formulations of glycyrrhizin
TABLE III - Permeability parameters for the different formulations
Formulation code Steady state flux Jss (µg/cm-2/h-1) 
Permeation 
coefficient (P) 
Kp (×10-3 cm h-1)
CG 02.50± 0.7 0.25± 0.06
NE1 14.51 ± 0.69 1.45 ± 0.64
NE2 14.93 ± 0.36 1.49 ± 0.30
NE3 13.85 ± 0.35 1.38 ± 0.32
NE4 13.45± 0.50 1.34 ± 0.40
NE5 13.28 ± 0.54 1.32± 0.45
NG2 13.49 ± 0.36 1.34 ± 0.04
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appropriate pH values, and the glycyrrhizin was incor-
porated into the oily phase of nanoemulsions, avoiding 
contact with water in the external phase. Hydrolysis of 
glycyrrhizin in nanoemulsions was not detected during 6 
months. It is likely that the nanoemulsion provided an inert 
circumstance and appropriate pH value for glycyrrhizin. 
Therefore, glycyrrhizin in nanoemulsions was effectively 
protected from degradation.
In vitro permeation studies
The nanoemulsion formulations were tested for 
percutaneous permeation, as shown in Table III. The per-
meation profiles of glycyrrhizin through human cadaver 
skin, from various vehicles, are shown in Figures 3-6. A 
steady increase of glycyrrhizin in the receptor chambers 
was observed over time. The permeation profiles of nano-
emulsions followed zero-order release kinetics. Statistical 
comparison of the flux throughout 24 hours showed that 
most of the nanoemulsions provided fluxes (P < 0.05) high-
er than the aqueous solution containing 1% glycyrrhizin. 
Figure 3 shows that the permeated amounts of glycyrrhizin 
from the different vehicles – except NE2 – presented no 
difference before 10 hours. However, significant differ-
ence between nanoemulsions and the aqueous solution 
was observed at the end of experiments. Additionally, 
the permeation flux from the aqueous solution decreased 
significantly after 10 hours. This revealed the inability 
of the aqueous solution to provide prolonged delivery of 
glycyrrhizin. This phenomenon may have been a result of 
depletion of driving concentration in the donor chamber.
Formulations NE1 and NE3, containing a lower 
amount of Span 80, Brij 35 and isopropyl alcohol, 
provided higher flux (P < 0.05) than ME2 and ME4, 
respectively. The content of surfactant mixture in na-
noemulsions significantly affected the skin permeation 
flux of glycyrrhizin. This may be due to increased ther-
modynamic activity of the drug in nanoemulsions at the 
lower concentration of surfactant and cosurfactant (Rhee 
et al., 2001). The thermodynamic activity of drug in the 
formulation is a significant driving force for the release 
and penetration of the drug into the skin (Walters et al., 
1998). The thermodynamic driving force for release re-
flects the relative activities of the drug in different phases 
(Delgado-Charro et al., 1997). Since the drug can be re-
leased from the internal phase to external phase and then 
from the external phase to the skin, the relative activities 
may monitor the skin permeation flux. The depletion of 
glycyrrhizin in the external phase due to permeation into 
the skin can be supplemented by the release of glycyr-
rhizin from the internal phase. Then, zero-order release 
kinetics and sustained, controlled and prolonged delivery 
of glycyrrhizin were obtained. This may also be the main 
mechanism of permeation of glycyrrhizin into the skin 
from these nanoemulsions. Passive drug permeation 
across the skin can be increased with a transdermal per-
meation enhancer that can reversibly remove the barrier 
resistance. Enhancers can increase the transport through 
skin by modifying the diffusion or partition coefficient 
of the drug (Naik et al., 2000). Ideally, an effective 
permeation enhancer should cause minimal tissue dam-
age and toxicity, especially for chronic applications. In 
this experiment, significant skin permeation-enhancing 
effects were observed. In vitro skin permeation studies 
were performed to compare drug release from five dif-
ferent nanoemulsion formulations (NE1-NE5), NG2 and 
CG all containing the same amount (1% wt/wt) of MAG. 
In vitro skin permeation was highest in formulation NE2 
and lowest for CG (Figures 3 and 5). 
Values represented as mean ± SEM (n = 3); NE stands for 
nanoemulsion
FIGURE 3 - Percentage of cumulative drug permeation for the 
various nanoemulsions through human cadaver skin.
FIGURE 4 - Steady-state transdermal flux of glycyrrhizin across 
human cadaver skin.
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Formulation NG2 showed an intermediate skin per-
meation profile. The skin permeation profile for N2 was 
significantly different when compared with that of CG and 
NG2 (P < 0.05). The significant difference in glycyrrhizin 
permeation between nanoemulsion formulations NG2 
and CG was probably due to the mean size of the internal 
phase droplets, which were significantly smaller in the 
nanoemulsions. The maximum release in NE2 could have 
been due to this formulation having the lowest droplet size 
and lowest viscosity of all nanoemulsions. Increase of the 
loading dose is widely known as an effective method to 
improve the skin permeation rate of various compounds 
(Reifenrath et al., 1981). The permeation rate of mono 
ammonium glycyrrhizate was almost linearly improved as 
a function of the loading dose and the permeation of nano-
emulsions, in accordance with Fick’s first law of diffusion. 
A high loading dose of mono ammonium glycyrrhizate 
can lead to increased flux. The effect of mono ammonium 
glycyrrhizate on skin irritation was studied by the Utelly 
test, and results showed that a hydroalcoholic solution con-
taining 10 µg/mL of MAG could induce obvious erythema 
and edema on both intact and rat skins (Utelly, 1973). The 
previous investigation about nanoemulsions with 1% glyc-
yrrhizin validated the anti-inflammatory activity (Ohuchi, 
Tsurufuji; 1982). Therefore, the suitable concentration of 
glycyrrhizin in nanoemulsions would be 1%. In a previous 
work, all the nanoemulsion formulations contained a large 
amount of surfactants and cosurfactant, with a powerful 
ability to perturb the stratum corneum. Furthermore, the 
best formulation, consisting of 46% soyabean oil, 50% 
Smix/isopropyl alcohol (5:1) and water is a w/o type of 
nanoemulsion. MAG dissolved in the inner phase of the 
w/o nanoemulsion might come into direct contact with the 
surface of the skin. This is suitable for long-term use, from 
a safety perspective. Therefore, formulation NE2 should 
be the most valuable for the further exploration.
Skin irritation studies
The irritation studies did not show visible irritation 
after application of NE2 for 3 days on the skin of rats, 
with no erythema or edema observed. Only rubefaction 
occasionally appeared on the skin of some rats on the first 
or second day, disappearing on the last day. The encapsula-
tion of the nanoemulsion might reduce the skin irritation 
induced by MAG. The results suggest that this nanoemul-
sion system for the transdermal delivery of MAG is viable.
CONCLUSIONS
The nanoemulsions containing MAG were studied 
for transdermal delivery. The different nanoemulsion for-
mulations were selected using the pseudo-ternary phase 
diagrams. The order of the addition of Smix is a very 
important factor for the preparation of nanoemulsions. 
The incorporation of MAG into nanoemulsions led to 
significant increase in droplet size, due to their location in 
the interfacial film. In vitro permeation studies showed that 
nanoemulsions with lower content of surfactant mixture 
could increase transdermal capacity. The MAG-loaded na-
noemulsions showed controlled, sustained and prolonged 
delivery. The permeation rates observed for MAG from 
nanoemulsions were in accordance with Fick’s first law of 
diffusion. In vitro skin permeation studies were performed 
to compare the release of drug from 5 different nanoemul-
sion formulations (NE1-NE5), NG2 and CG, all contain-
ing the same amount (1% wt/wt) of MAG. In vitro skin 
permeation was highest for formulation NE2 and lowest 
for CG (Figures 3 and 5). Formulation NG2 showed an 
intermediate skin permeation profile. The skin permeation 
Values represented as mean ± SEM (n = 3), NE2 stands for 
nanoemulsion 2, NG2 stands for nanoemulsion gel 2, CG stands 
for conventional gel
FIGURE 5 - Graphic representation of cumulative drug release 
for CG, NE2 and NG2.
FIGURE 6 - Transmission electron microscopic positive image 
of glycyrrhizin nanoemulsion showing the size of some droplets.
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profile for N2 was significantly different when compared 
to that of CG and NG2 (P < 0.05). The significant differ-
ence in glycyrrhizin permeation between nanoemulsion 
formulations NG2 and CG was probably due to the mean 
size of internal phase droplets, which were significantly 
smaller in nanoemulsions. The maximum release in NE2 
could be due to this formulation having the lowest droplet 
size and the lowest viscosity of all nanoemulsions.
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